|
Mar 13
|
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
|
|
Mar 5
|
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
|
|
Jan 3
|
Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?
|
|
Dec 13
|
Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
|
|
Dec 6
|
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
|
|
Nov 8
|
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
|
|
Nov 4
|
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Q3 2023 Vir Biotechnology Inc Earnings Call
|
|
Nov 2
|
Vir Biotechnology Inc (VIR) Reports Q3 2023 Financial Results
|
|
Nov 2
|
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
|
|
Aug 29
|
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
|
|
Jun 29
|
Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer
|
|
Apr 28
|
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 27
|
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q1 Earnings Expected to Decline
|